1. Stocks
    2. /
  2. Pfizer (NYSE: PFE)
    3. /

Pfizer (NYSE: PFE) Share Price and News

$25.21 $-0.71 (-2.7%) 19 June 2026 at 6:00:00 am AEST

Pfizer Chart and Price Data

About Pfizer

Last updated 19-06-2026, 06:00:00am AEST
Current Price $25.21
Change $-0.71 (-2.7%)
Close Price $25.21
Open Price $25.58
Bid $25.24
Ask $25.26
Day Range $24.94 - $25.66
Year Range $23.11 - $28.75
Volume 119,614,340
Average Volume 37,278,406
Market Cap $143,682,882,400.00
Earnings Per Share $1.30

    • Pfizer (NYSE: PFE)
    Latest News

    A hand holding a pin about to burst a balloon, indicating a crash or drop in asx shares
    Share Market News

    Will Pfizer's COVID-19 vaccine end the ASX tech share rally?

    | Bernd Struben

    With Pfizer's announcement of a promising COVID-19 vaccine, ASX tech shares are largely missing out on the global share market…

    Read more »

    vaccine
    Share Market News

    ASX 200 to surge higher after Pfizer COVID-19 vaccine success

    | James Mickleboro

    It looks set to be a fantastic day for the S&P/ASX 200 Index (ASX:XJO) on Tuesday after strong results from Pfizer's COVID-19…

    Read more »

    virus image
    International Stock News

    Pfizer and BioNTech coronavirus vaccine accepted for rolling review in Canada

    | Eric Volkman

    Health Canada will determine BNT162b2's suitability for approval as clinical trial data comes in.

    Read more »

    person receiving coronavirus vaccine injection into the arm
    International Stock News

    3 reasons Pfizer and BioNTech will have coronavirus vaccine data before Moderna

    | Brian Orelli, PhD

    Different clinical trial designs gives the duo an advantage, but coming in first isn't the end goal for vaccine makers.

    Read more »

    doctor giving little boy vaccine injection in his arm
    International Stock News

    Johnson & Johnson (NYSE:JNJ) starts late-stage coronavirus vaccine clinical trial

    | Brian Orelli, PhD

    The phase 3 study of JNJ-78436735, which will enroll 60,000 participants, is underway.

    Read more »

    gloved hand injecting coronavirus vaccine into person's arm
    International Stock News

    Coronavirus vaccine trial adverse event was probably unrelated to treatment

    | Brian Orelli, PhD

    The paused clinical trial has already resumed.

    Read more »

    vaccine shot
    International Stock News

    Pfizer says it could know if its COVID-19 vaccine candidate works in October

    | Todd Campbell

    The drugmaker's CEO said there was a more than 60% chance that they would know by the end of next…

    Read more »

    doctor making thumbs up gesture and holding vial labelled 'covid-19 vaccine' representing covid shares
    International Stock News

    The surefire vaccine winner following AstraZeneca's COVID-19 trial pause

    | Keith Speights

    Hint: It's not Moderna.

    Read more »

    vaccine
    International Stock News

    What if more than one company wins the coronavirus vaccine race?

    | Alex Carchidi

    The ability to globally distribute a vaccine is as important as the vaccine itself. To the best-equipped victors go the…

    Read more »

    CSL share price represented by hand in blue glove picks out a vial labelled 'covid-19 vaccine' from a row of vials
    International Stock News

    Coronavirus vaccine race: 7 key things you'll want to know

    | Keith Speights

    Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.

    Read more »

    Patient wearing mask gets COVID vaccine injection
    International Stock News

    AstraZeneca coronavirus vaccine clinical trial paused

    | Brian Orelli, PhD

    One participant fell ill, but the connection to treatment with AZD122 is unclear.

    Read more »

    covid-19 vaccine
    International Stock News

    How to invest in coronavirus vaccine stocks

    | Keith Speights

    Just follow these three simple steps.

    Read more »

    Profile

    since

    Note